Position
Renaissance Technologies in Sutro Biopharma, Inc.
Back to the book · All holders of STRO
Estimated mark uses implied 13F prices (value ÷ shares). Adds are treated as happening at this quarter’s mark; cuts at last quarter’s. Share jumps can be splits, not buys. This is not realized P&L.
Latest estimated mark $715.6K$24.91 → $33.20
| Quarter | Shares | Value | Implied px | Est. mark | Flow | Weight |
|---|---|---|---|---|---|---|
| Q4 2025 | 122.9K | $1.42M | — | — | — | 0.0% |
| Q1 2026 | 97.8K | $2.44M | $24.91 | $1.3M | −$289.7K | 0.0% |
| Q2 2026 | 86.3K | $2.87M | $33.20 | $715.6K | −$286.5K | 0.0% |